KKR said late Thursday it acquired a significant minority stake in Arbor Pharmaceuticals. Financial terms weren’t announced. Atlanta-based Arbor is specialty pharmaceutical company currently focused on the cardiovascular, hospital, and pediatric markets. KKR’s investment is coming from its North America XI private equity fund. Lazard Middle Market advised Arbor.